(S)-1-(5-chloro-2-((3,5-difluorophenyl)amino)pyrimidin-4-yl)-N-(3-(morpholine-4-carbonyl)-4-(piperidin-1-yl)phenyl)pyrrolidine-2-carboxamide

ID: ALA4876323

PubChem CID: 164628515

Max Phase: Preclinical

Molecular Formula: C31H34ClF2N7O3

Molecular Weight: 626.11

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(Nc1ccc(N2CCCCC2)c(C(=O)N2CCOCC2)c1)[C@@H]1CCCN1c1nc(Nc2cc(F)cc(F)c2)ncc1Cl

Standard InChI:  InChI=1S/C31H34ClF2N7O3/c32-25-19-35-31(37-23-16-20(33)15-21(34)17-23)38-28(25)41-10-4-5-27(41)29(42)36-22-6-7-26(39-8-2-1-3-9-39)24(18-22)30(43)40-11-13-44-14-12-40/h6-7,15-19,27H,1-5,8-14H2,(H,36,42)(H,35,37,38)/t27-/m0/s1

Standard InChI Key:  BEKSYPNJBZULPN-MHZLTWQESA-N

Molfile:  

 
     RDKit          2D

 44 49  0  0  0  0  0  0  0  0999 V2000
   19.5185  -13.2666    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3216  -13.4372    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1806  -12.1182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.5169  -12.1845    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.0721  -10.8320    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.8745  -11.2221    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4296  -12.4526    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.7438  -12.4567    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   17.2917  -11.2274    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.9049  -11.6358    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2981  -12.0462    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1195  -10.5090    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   15.8773  -12.0484    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5675  -12.4085    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7405  -11.6054    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1767  -12.9591    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.7292  -12.7265    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1306  -11.0586    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.7364  -10.7643    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.1634  -10.8129    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7190  -12.0450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4545  -12.0489    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1610   -9.9921    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   16.5884  -12.4556    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.0057  -12.4538    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.7181  -11.2233    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5154  -11.3520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1652  -12.4577    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.1259  -11.8949    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9577  -12.7029    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3506  -11.3150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4557  -11.2257    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9980  -10.8121    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.5672  -13.2439    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.3980  -14.0444    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0032  -14.5881    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7812  -14.3368    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.9504  -13.5363    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3416  -12.9872    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.8560  -10.5780    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0244   -9.7782    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.4145   -9.2281    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.6333   -9.4836    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.4620  -10.2892    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 24 11  1  0
 22 28  1  0
 16 30  2  0
 14 16  1  0
 29 27  2  0
 26 12  1  0
 27 15  1  0
 13 24  1  0
 30 29  1  0
 10  4  2  0
 20 32  1  0
 20 23  1  0
 25 21  1  0
 22  8  1  0
 28 13  2  0
 10  5  1  0
 31 18  1  0
 26 33  1  0
 21 26  2  0
  3 31  1  6
  3  7  1  0
 11 25  2  0
 31 19  2  0
  6 20  2  0
 32 22  2  0
 17  3  1  0
  1  2  1  0
 21  7  1  0
 13  6  1  0
  7  1  1  0
  2 17  1  0
 18 15  1  0
  9 11  1  0
 29 10  1  0
 15 14  2  0
 33  9  2  0
 34 35  1  0
 34 39  1  0
 35 36  1  0
 36 37  1  0
 37 38  1  0
 38 39  1  0
 30 34  1  0
  5 40  1  0
  5 44  1  0
 40 41  1  0
 41 42  1  0
 42 43  1  0
 43 44  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4876323

    ---

Associated Targets(Human)

KM12 (47707 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H2228 (1030 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KARPAS-299 (888 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 626.11Molecular Weight (Monoisotopic): 625.2380AlogP: 5.22#Rotatable Bonds: 7
Polar Surface Area: 102.93Molecular Species: NEUTRALHBA: 8HBD: 2
#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.06CX Basic pKa: 4.40CX LogP: 5.33CX LogD: 5.33
Aromatic Rings: 3Heavy Atoms: 44QED Weighted: 0.37Np Likeness Score: -1.84

References

1. Li T, Li C, Yang J, Guo M, Cao Z, Wang X, Jiang N, Zhai X..  (2021)  Discovery of novel 2-phenylamino-4-prolylpyrimidine derivatives as TRK/ALK dual inhibitors with promising antitumor effects.,  47  [PMID:34534734] [10.1016/j.bmc.2021.116396]

Source